New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway

E-ISSN： 1873-4286|12|3|327-340

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.3, 2006-01, pp. : 327-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma

Current Medicinal Chemistry, Vol. 21, Iss. 27, 2014-09 ,pp. : 3173-3187

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting signalling pathways for the treatment of multiple myeloma

By Podar Klaus Hideshima Teru Chauhan Dharminder Anderson Kenneth C

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 359-381

Informa Healthcare

Access to resources Recommend Favorite

Anti-Cancer Therapy: Targeting the Mevalonate Pathway

Current Cancer Drug Targets, Vol. 6, Iss. 1, 2006-02 ,pp. : 15-37

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Mevalonate Pathway for Improved Anticancer Therapy

Current Cancer Drug Targets, Vol. 9, Iss. 5, 2009-08 ,pp. : 626-638

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment Strategies in Elderly Patients with Multiple Myeloma: Current Status

By Quach Hang Prince H. Miles Mileshkin Linda

Drugs & Aging, Vol. 24, Iss. 10, 2007-01 ,pp. : 829-850

Adis International

Access to resources Recommend Favorite